Cognitive Status and Quality of Life After Treatment for Primary CNS Lymphoma
Neurol 62:544-547,532, Harder,H.,et al, 2004
Targeting Calcitonin Gene-Related Peptide: A New Era in Migraine Therapy
Lancet 394:1765-1774, Charles, A. & Pozo-Rosich, P., 2019
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
NEJM 378:708-718, Albers, G.W.,et al, 2018
Benefits of Emergency Departments Contribution to Stroke Prophylaxis in Atrial Fibrillation
Stroke 48:1344-1352, Coll-Vinent, B.,et al, 2017
Subarachnoid Hemorrhage
NEJM 377:257-266, Lawton, M.T. & Vates, G.E., 2017
Surgery for Drug-Resistant Epilepsy in Children
NEJM 377:1639-1647, Dwivedi, R.,et al, 2017
Dexamethasone & Supportive Care with or without Whole Brain Radiotherapy in Treating Patients with Non-Small Cell Lung Cancer with Brain Metastases Unsuitable for Resection or Stereotactic Radiotherapy (QUARTZ): Results from a Phase 3,Non-Inferiority, Randomised Trial
Lancet 388:2004-2014, Mulvenna, P.,et al, 2016
Myasthenia Gravis
NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016
Resective Epilepsy Surgery for Drug-Resistant Focal Epilepsy
JAMA 313:285-293, Jobst, B.C. & Cascino, G.D., 2015
Palliative and End-Of-Life Care in Stroke
Stroke 45:1887-1916, Holloway, R.G.,et al, 2014
Long-Term Cognitive Function, Neuroimaging and Quality of Life in Primary CNS Lymphoma
Neurol 81:84-92, Doolittle, N.,et al, 2013
Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy
JAMA 307:922-930,966,985, Engel,J.,et al, 2012
Early Surgical Therapy for Drug-Resistant Temporal Lobe Epilepsy
JAMA 307:922-930, Engel, J.,et al, 2012
The Cost-Effectiveness of Telestroke in the Treatment of Acute Ischemic Stroke
Neurol 77:1590-1598, Nelson, R.E.,et al, 2011
Mailuoning for Acute Ischemic Stroke
Stroke 41:e443-e444, Weimin,Y.,et al, 2010
Best Practice Recommendations for the Selection and Management of Patients with Multiple Sclerosis Receiving Natalizumab Therapy
Mutliple Sclerosis 15:S26-S36, Coyle,P.K.,et al, 2009
Spinal Cord Compression in Patients With Advanced Metastatic Cancer
JAMA 299:937-946, Abrahm,J.L.,et al, 2008
Epilepsy Surgery for Pharmacoresistant Temporal Lobe Epilepsy: A Decision Analysis
JAMA 300:2497-2505,2548, Choi,H.,et al, 2008
Radiotherapy for Glioblastoma in the Elderly
NEJM 356:1527-1535, Keime-Guibert,F.,et al, 2007
Health-Related Quality of Life in Multiple Sclerosis: Effects of Natalizumab
Ann Neurol 62:335-346, Rudick,R.A.,et al, 2007
Central Nervous System Injury Associated with Cardiac Surgery
Lancet 368:694-703, Newman,M.F.,et al, 2006
Effect of Timing and Method of Enteral Tube Feeding For Dysphagic Stroke Patients (FOOD): a Multicentre Randomised Controlled Trial
Lancet 365:764-772, 729, The FOOD Trial Collaboration, 2005
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
Training Care Givers of Stroke Patients: Randomised Controlled Trial
BMJ 328:1099-1101, Kalra,L.,et al, 2004
Training Care Givers of Stroke Patients: Economic Evaluation
BMJ 328:1102-1104, Patel,A.,et al, 2004
Immediate Computed Tomography Scanning of Acute Stroke is Cost-Effective and Improves Quality of Life
Stroke 35:2477-2483, Wardlaw,J.M.,et al, 2004
Pharmaceutical Interventions for Emotionalism After Stroke
Stroke 35:2610-2611, Horrocks,J.A.,et al, 2004
A 48-Year-Old Man With Temporal Lobe Epilepsy and Psychiatric Illness
JAMA 290:381-392, Devinsky,O., 2003
Surgical Decompression of Patients with Large Middle Cerebral Artery Infarcts is Effective
Stroke 34:2304-2305,2307, Schwab,S.&Hacke,W., 2003
Surgical Decopression of Patients With Large Middle Cerebral Artery Infarcts is Effective:Not Proven
Stroke 34:2305-2306,2307, Brown,M.M., 2003
Physician Advice, Patient Actions, and Health-Related Quality of Life in Secondary Prevention of Stroke Through Diet and Exercise
Stroke 33:565-571,570, Greenlund,K.J.,et al, 2002
A Randomized, Controlled Trial of Surgery for Temporal-Lobe Eiplepsy
NEJM 345:311-318,365, Wiebe,S.,et al, 2001
Randomized Controlled Trial of Integrated (Managed) Care Pathway for Stroke Rehabilitation
Stroke 31:1929-1934, Sulch,D. et al, 2000
Family Support for Stroke: a Randomised Controlled Trial
Lancet 356:808-813, Mant,J. et al, 2000
Cost and Outcome of Mechanical Ventilation for Life-Threatening Stroke
Stroke 31:2346-2353, Mayer,S.A.,et al, 2000
Patient-Oriented Outcome Assessment After Temporal Lobectomy for Refractory Epilepsy
Neurol 53:687-694, 662, Gilliam,F.,et al, 1999
Cost-Effectiveness of Tissue Plasminogen Activator for Acute Ischemic Stroke
Neurol 50:883-890, Fagan,S.C.,et al, 1998
A 29-Year-Old Man with Multiple Sclerosis
JAMA 280:1432-1439, Rudick,R.A., 1998
Frequent & Frequently Overlooked:Trtm-Induced Endocrine Dysf in Adult Long-Term Survivors of Primary Brain Tumors
Neurol 49:498-506, Arlt,W.,et al, 1997
A Stroke-Adapted 30-Item Version of the Sickness Impact Profile to Assess Quality of Life (SA-SIP30)
Stroke 28:2155-2161, van Straten,A.,et al, 1997
Generalized Anxiety Disorder in Stroke Patients
Stroke 27:270-275, Astrom,M., 1996
Quality of Life After Stroke
Stroke 27:1467-1472, King,R.B., 1996
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Radiotherapy for Malignant Glioma
BMJ 313:1500-1501, Gregor,A.,et al, 1996
Quality of Life After Stroke:Impact of Stroke Type and Lesion Location
Stroke 26:402-408, deHaan,R.J.,et al, 1995
Outcome Research in Neurology:Incorporating Health-Related Quality of Life
Ann Neurol 37:141-142, Devinsky,O., 1995
Outcome Assessment for Epilepsy Surgery:The Impact of Measuring Health-Related Quality of Life
Ann Neurol 37:158-166, 1411995., Vickrey,B.G.,et al, 1995
Cost-Effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients with Nonvalvular Atrial Fibrillation
JAMA 274:1839-1845, Gage,B.F.,et al, 1995
Outcomes in 248 patients who had Diagnostic Evaluations for Epilepsy Surgery
Lancet 346:1445-1449, Vickrey,B.G.,et al, 1995